Searched for
MYLAN EXECUTIVE CHAIRMAN
Temasek, TrueNorth-CPPIB seek to invest in Biocon BiologicsEye minority stake in Biocon Biologics; unit may be valued at $4 billion, higher than the market cap of Biocon.21 Aug, 2019, 07.03 PM IST- Culture of ‘bending rules’ in India challenges U.S. drug agencyThe US drug agency is bewildered with Indian pharma industry's culture of getting things done at all costs.31 Jan, 2019, 08.09 PM IST
- Top stocks in focus on 10 October 2017Here is a list of top stocks that are likely to be in focus in today's trading session.10 Oct, 2017, 09.54 AM IST
- Cipla reshuffles its senior management team againIndia’s third-largest drug maker Cipla has reshuffled its senior management team, the third time it’s doing so in as many years.07 Dec, 2015, 04.00 AM IST
- Mylan fails in $26 bn bid to buy fellow drugmaker PerrigoMylan NV's $26 bn hostile bid for Perrigo collapsed on Friday after the Netherlands-based drugmaker failed to secure at least half of Perri...13 Nov, 2015, 09.50 PM IST
- Mylan rejects Teva's $40 billion merger offer as undervaluedDrug major Mylan has rejected a $40 billion unsolicited merger offer from Israel's Teva Pharmaceutical Industries calling the bid undervalu...28 Apr, 2015, 03.25 PM IST
- Teva’s hostile bid for Mylan: Deal could open up a $2-billion opportunity for pharma companiesAccording to experts, there is a possibility that the fruition of the deal will open up a $2-billion opportunity for Indian generic pharma ...23 Apr, 2015, 01.59 PM IST
- Mylan Inc to acquire Famy Care's certain business for $ 800 millionMumbai-based Famy Care is focused on female reproductive health care and is world leader in supplying a wide range of contraceptive pills.02 Feb, 2015, 09.37 PM IST
- Venus Pharma ties up with Mylan for marketing of antibiotic MeropenemThe deal with Mylan will enable Venus Remedies to market meropenem in Denmark, Sweden and Finland for a period of five years.08 Sep, 2014, 01.33 PM IST
- Biocon posts 15% rise in revenue, names new CEOBiocon, the country's largest biotech company, reported a 15% rise in fourth-quarter revenue to 746 crore, helped by a 17% rise in sales at...26 Apr, 2014, 04.59 AM IST
- Agila, with first class people, is a very high-quality asset: Rajiv MalikMylan has completed the acquisition of Agila Specialties division from Strides Arcolab for a total value of $1.75 billion (about Rs10,800 c...07 Dec, 2013, 04.41 AM IST
- AIF Capital to invest $40 mn in Famy CareAIF Capital, one of the largest Asia-based independent private equity firms, on Wednesday announced that AIF Capital Asia III, LP has inves...21 Apr, 2010, 05.52 PM IST
- Matrix weighs Docpharma saleHyderabad-based Matrix Labs, in which US-based Mylan Labs holds a controlling stake, is toning up its business focus.29 Feb, 2008, 12.04 AM IST
- Mylan makes open offer for 20% stake in MatrixMP Laboratories (Mauritius) Ltd along with US-based generic pharma firm Mylan Laboratories Inc has issued an open offer to the shareholders...29 Aug, 2006, 06.50 PM IST
- US pharma major Mylan buys Matrix LabsThe generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.29 Aug, 2006, 01.58 AM IST
- Mylan Labs to acquire 71.5% stake in MatrixIndian drug maker Matrix Laboratories Ltd on Monday said US-based generic pharma firm Mylan Laboratories Inc will acquire upto 71.5 per cen...28 Aug, 2006, 11.40 AM IST
- Mylan to buy into MatrixMylan Laboratories’ India foray may be just round the corner - the US company is set to pick up a major stake in Secunderabad-based Matrix ...28 Aug, 2006, 04.18 AM IST
Load More
